• 医学文献
  • 知识库
  • 评价分析
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
论文 期刊
高级检索

检索历史 清除

胆囊癌患者凝血功能变化及其临床意义

Change of coagulation in patients with gallbladder cancer and its clinical significance

摘要:

目的 探讨胆囊癌患者凝血功能变化与临床病理特征间的关系.方法 回顾2007年1月至2013年6月收治的64例胆囊癌患者(胆囊癌组)和60例胆囊炎患者(对照组)的血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(Fib)、凝血酶时间(TT).比较胆囊癌患者凝血功能的变化及上述指标与胆囊癌患者预后的关系.结果 与对照组比较,胆囊癌组患者APTT明显缩短[(29.0±4.2)s,t=-4.265,P=0.000],PT[(11.5±1.4)s]、TT[(15.3±3.5)s]延长(t=2.521、4.147,P<0.05)、Fib明显升高[(4.1 ±0.9)g/L,t=4.365,P=0.000].中、低分化腺癌患者Fib高于高分化腺癌患者(F=4.069,P=0.022),有淋巴结转移患者Fib明显高于无淋巴结转移者(t=2.640,P=0.010),TNMⅡ~Ⅳ期患者Fib明显高于0~Ⅰ期患者(t=3.003,P<0.01).胆囊癌患者伴高纤维蛋白原血症比例(32/64)明显高于对照组(11/60,x2=13.709,P<0.01).且与胆囊癌Fib正常者相比,在肿瘤分化程度(x2=7.760)、浸润深度(x2=10.573)、淋巴结转移情况(x2=6.063)及病理分期(x2=5.851)差异均有统计学意义(P<0.05).胆囊癌伴高纤维蛋白原血症患者与胆囊癌Fib正常患者中位生存率分别为8.63个月和16.73个月,1、3年生存率分别为64.7%、14.9%和74.9%、21.1%,差异有统计学意义(P<0.05).结论 胆囊癌患者血清Fib水平在术前辅助评估疾病进展及预后等方面有一定的临床应用价值.

更多
abstracts:

Objective To study the relationship between the change of coagulation and the clinicopathologic characteristics in patients with gallbladder cancer.Methods The 64 gallbladder cancer patients (GBC group) and 60 cholecystitis patients (control group) had been reviewed from January 2007 to June 2013.The prothrombin time (PT),activated partial thromboplastin time (APTT),fibrinogen (Fib),and thrombin time (TT) had been measured and compared between patients of GBC group and control group.The relationship of coagulation function and prognosis were analyzed.Results Compared with control group,APTT in GBC group ((29.0 ± 4.2) s) was significantly shortened (t =-4.265,P =0.000) and PT ((11.5 ± 1.4) s),TT ((15.3 ± 3.5) s),Fib ((4.1 ± 0.9) g/L) were significantly increased in GBC group (t =2.521,4.147 and 4.365,all P < 0.05).The level of Fib was higher in patients with medium or poor-differentiated tumor cells (F =4.069,P =0.022),lymph metastasis (t =2.640,P =0.010) and advanced staging (Ⅱ-Ⅳ) (t =3.003,P < 0.01) than those of well-differentiated,non-lymph metastasis and early staging (0-Ⅰ).The ratio of gallbladder cancer with hyperfibrinogenemia (32/64) was significantly higher than control group (11/60,x2 =13.709,P < 0.01).In GBC group,compared with normal Fib patients,hyperfibrinogenemia patients showed significantly difference in clinicopathologic characteristics (x2 =5.851-10.573,P < 0.05).The average survival period of hyperfibrinogenemia patients and normal Fib patients were 8.63 months and 16.73 months.The 1-,3-year survival rate of patients with hyperfibrinogenemia were significantly lower than those with normal Fib (64.7%,14.9% vs.74.9%,21.1%,P < 0.05).Conclusion Preoperative plasma level of Fib might be a new promising biomarker in patients with gallbladder cancer for evaluating disease progression and prognosis.

More
作者: 包润发 [1] 束翌俊 [1] 董平 [1] 顾钧 [1] 吴向嵩 [1] 李茂岚 [1] 翁昊 [1] 丁倩 [1] 吴文广 [1]
第一作者: 包润发
作者单位: 200092,上海交通大学医学院胆道疾病研究所上海交通大学医学院附属新华医院普外科实验室 [1]
期刊: 《中华外科杂志》2013年51卷12期 1067-1070页 MEDLINEISTICPKUCSCD
栏目名称: 论著
DOI: 10.3760/cma.j.issn.0529-5815.2013.12.002
发布时间: 2014-01-09
基金项目:
国家自然科学基金资助项目
  • 浏览:173
  • 下载:31

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

充值 订阅 收藏 移动端 使用
帮助